Compare Immunovant Inc. Common Stock (IMVT) vs Quantum Computing Inc (QUBT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Immunovant Inc. Common Stock vs Quantum Computing Inc — how do they compare? Immunovant Inc. Common Stock trades at $30.01 (market cap $6.62B), while Quantum Computing Inc trades at $7.57 (market cap $1.72B). The key difference: Immunovant Inc. Common Stock is far larger — about 3.8× Quantum Computing Inc's market cap, and Immunovant Inc. Common Stock is trading nearer its 52-week high, Quantum Computing Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Immunovant Inc. Common Stock for 0 Days and Quantum Computing Inc for 25 Days on average.
| IMVT | QUBT | |
|---|---|---|
Market Cap | $6.62B | $1.72B |
Volume | 1,131,364 | 7,242,201 |
Sector | Health | Technology |
52-Week High | $44.96 | $21.78 |
52-Week Low | $17.03 | $6.31 |
Typical Hold Time | 0 Days | 25 Days |
Enterprise Value | $5.72B | $791.72M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Quantum Computing Inc. (QUBT) trades at $7.62, down 3.05% today, with a bearish technical signal despite bullish oscillators. The company shows explosive revenue growth from $682K in 2025 to $10M projected for 2026, but remains deeply unprofitable with a -152.45% net income margin. Recent developments include the Dirac-3S quantum system launch and a $42.5M backlog, though rising expenses and negative cash flow pose challenges.
Analysts maintain a bullish stance with a $17.33 consensus target (75% buy ratings), seeing potential in QCi's quantum technology expansion. However, execution risks, continued losses, and high valuation multiples (P/S 160.95) require careful consideration. The stock offers high-risk, high-reward potential for investors comfortable with speculative quantum computing plays.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →About Quantum Computing Inc
Quantum Computing Inc. is a company focused on providing accessible quantum computing and quantum-enhanced software solutions for complex problems. The company's technology is designed to run on both classical and quantum hardware, enabling businesses to explore the power of quantum computing today for applications in finance, drug discovery, and logistics. QUBT offers a platform that makes quantum algorithms and software available through the cloud, aiming to democratize access to this advanced computing paradigm.
Read more on QUBT →
